Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Single Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05285384
What this trial is testing

Immunogenicity and Safety of a Booster Dose of the SpikoGen Vaccine in Kidney Transplant Recipients After Two Doses of Sinopharm Vaccine

Who this might be right for
COVID-19
Cinnagen 43
Testing effectiveness (Phase 2)Study completedNCT03616184
What this trial is testing

Study of Ruxolitinib in Sclerotic Chronic Graft-Versus-Host Disease After Failure of Systemic Glucocorticoids

Who this might be right for
Graft-versus-host-disease (GVHD)
University of Nebraska 49
Testing effectiveness (Phase 2)UnknownNCT01456819
What this trial is testing

Intramuscular Mononuclear Cells and Mesenchymal Stem Cells Transplantation to Treat Chronic Critical Limb Ischemia

Who this might be right for
Critical Limb Ischemia
National University of Malaysia 50
Large-scale testing (Phase 3)Study completedNCT00008229
What this trial is testing

Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06362967
What this trial is testing

The Efficacy and Safety of Desensitation Regimen for Patients With High Titers of Anti-HLA Antibodies Prior to Allo-HSCT

Who this might be right for
High Titers of Anti-HLA Antibody (MFI ≥5000)
Anhui Provincial Hospital 30
Testing effectiveness (Phase 2)WithdrawnNCT03168100
What this trial is testing

2017-03: A Single-Arm, Open-label Study of Anti-Signaling Lymphocytic Activation Molecule F7 (Anti-SLAMF7) Monoclonal Antibody (mAb) Therapy After Autologous Stem Cell Transplant in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas
Early research (Phase 1)Study completedNCT00409929
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of AEB071

Who this might be right for
Healthy
Novartis 16
Post-approval studies (Phase 4)Study completedNCT03216967
What this trial is testing

Multicenter Randomized Two-arms Study Evaluating the BK Viral Clearance in Kidney Transplant Recipients With BK Viremia.

Who this might be right for
BK Virus Nephropathy After Kidney Transplantation
University Hospital, Strasbourg, France 130
Not applicableNo Longer AvailableNCT00799539
What this trial is testing

Further Assess Safety and Effectiveness Data of the Bortezomib(Velcade)/Melphalan/Prednisone (BMP) Regimen in Previously Untreated and Transplant Ineligible Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Janssen-Ortho Inc., Canada
Not applicableNot Yet RecruitingNCT07384572
What this trial is testing

Perioperative Recovery Outcomes With a Spontaneous Breathing Strategy in Severely Underweight Lung Transplant Recipients

Who this might be right for
End-stage Lung Disease
The First Affiliated Hospital of Guangzhou Medical University 56
Post-approval studies (Phase 4)Study completedNCT00609388
What this trial is testing

Tacrolimus During the Implantation and the Effect on Ischemia-reperfusion Injury in Liver Transplantation

Who this might be right for
Ischemia Reperfusion Injury
Medical University of Vienna 26
Large-scale testing (Phase 3)Study completedNCT00565331
What this trial is testing

Rituximab for Prevention of Rejection After Renal Transplantation

Who this might be right for
Kidney Transplantation
Radboud University Medical Center 280
Large-scale testing (Phase 3)UnknownNCT03770975
What this trial is testing

Comparison of Peri Implant Soft Tissue Esthetics With Immediate Temporization With and Without Subepithelial Connective Tissue Graft

Who this might be right for
Immediate Temporization and Soft Tissue Augmentation Around Delayed Implants
Cairo University 22
Testing effectiveness (Phase 2)Ended earlyNCT02592876
What this trial is testing

Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lymphoma

Who this might be right for
Lymphoma, B-cellLymphoma, Large B-Cell, DiffuseLymphoma, Follicular, Grade 3b+1 more
Seagen Inc. 81
Post-approval studies (Phase 4)Study completedNCT03864926
What this trial is testing

Envarsus in Delayed Graft Function (E-DGF)

Who this might be right for
Delayed Graft Function
University of Wisconsin, Madison 100
Testing effectiveness (Phase 2)Study completedNCT03491215
What this trial is testing

Study of Pharmacokinetics, Activity and Safety of Ruxolitinib in Pediatric Patients With Grade II-IV Acute Graft vs. Host Disease

Who this might be right for
Acute Graft Versus Host Disease
Novartis Pharmaceuticals 45
Post-approval studies (Phase 4)Study completedNCT06616415
What this trial is testing

A Clinical Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Belumosudil in Chinese Adolescents With cGVHD Who Have Had an Inadequate Response to Glucocorticoids or Other Systemic Therapies

Who this might be right for
Chronic Graft Versus Host Disease
Sanofi 6
Not applicableStudy completedNCT01025037
What this trial is testing

Outcomes in Rotator Cuff Repair Using Graft Reinforcement

Who this might be right for
Rotator Cuff Tear
Stryker Trauma and Extremities 61
Not applicableStudy completedNCT00855569
What this trial is testing

Hemostatic Textile to Control Bleeding at Donor Graft Sites

Who this might be right for
Wounds
University of North Carolina, Chapel Hill 20
Not applicableStudy completedNCT03333941
What this trial is testing

Continued Access to the Recell® Device for Treatment of Acute Burn Injuries

Who this might be right for
Burns
Avita Medical 76
Next Page